Showing results (51-60 of 397) with videos related to
Sort By:
Pageof 40
Journal of Immunological Methods|January 1, 1981
beta 1H-hemagglutination assay: a highly sensitive test for human beta 1H and its usesM Schmitt, H H Mussel, M P DierichZeitschrift Fur Hautkrankheiten|July 1, 1990
[Human immunodeficiency virus (HIV): a review]T F Schulz, C Larcher, M P DierichWiener Klinische Wochenschrift|July 22, 1999
The complement system: pathophysiology and clinical relevanceC Speth, R Würzner, H Stoiber, et al.Scandinavian Journal of Immunology|April 28, 2006
Minimal residual disease in ovarian cancer as a target for complement-mediated mAb immunotherapyL Bjørge, H Stoiber, M P Dierich, et al.Arzneimittel-Forschung|April 1, 1991
Spectrum of in vitro antifungal activity of ditiocarb sodiumF Allerberger, G Roberts, E Reisinger, et al.The Pediatric Infectious Disease Journal|April 17, 2001
Hemolytic-uremic syndrome surveillance to monitor trends in infection with Escherichia coli O157 and non-O157 enterohemorrhagic E. coli in AustriaH Fischer, P König, M P Dierich, et al.European Journal of Immunology|December 1, 1979
Detection of proteolytic (C 3-cleaving) activity on mouse mastocytoma (P 815) cells and other mouse cell lines by formation of cell contact with C 3-carrying mouse lymphocytesM P Dierich, T Schulz, E Yefenof, et al.Pneumologie (Stuttgart, Germany)|April 1, 1992
[Calcofluor-white staining in the identification of Pneumocystis carinii]F Allerberger, C Prior, D Niederwieser, et al.Wiener Klinische Wochenschrift|January 1, 1993
[Antibacterial chemotherapy of "septic kidney"]G Janetschek, J Girstmair, E Semenitz, et al.European Journal of Immunology|January 1, 1995
Decay-accelerating factor (CD55) protects human immunodeficiency virus type 1 from inactivation by human complementP Marschang, J Sodroski, R Würzner, et al.Pageof 40